Are there any questions in tobacco control you would like to see answered?
The Cochrane Tobacco Addiction Group would like to ask you where you would like to see further research, or where you feel that there is still uncertainty about ways to prevent or treat tobacco addiction. The prioritisation survey will be the first of its kind to identify pressing unanswered questions about the prevention and treatment of tobacco addiction.
Your questions can be in any order of importance, and they can be about policies or interventions for smoking tobacco, smokeless tobacco (e.g. snus, chewing tobacco) or waterpipe tobacco use (e.g. hookah, shisha).
The views gathered in this survey will be published in a reputable journal, and will be used to inform the future research priorities for the entire tobacco addiction research community.
Find out more about the project here.
The Cochrane Tobacco Addiction Group forms part of The Cochrane Collaboration, an international not-for-profit and independent organisation which produces and disseminates systematic reviews of healthcare interventions and promotes the search for evidence in the form of clinical trials and other studies of interventions. The major product of the Collaboration is the Cochrane Database of Systematic Reviews which is published monthly as part of The Cochrane Library.
The Tobacco Addiction Group reviews the evidence on interventions to prevent and treat tobacco addiction. We include interventions for smoking cessation, for preventing uptake, and public policy interventions to reduce smoking prevalence. We also provide editorial support for a limited number of reviews that do not fit the remit of other Cochrane Review Groups.
The co-ordinating editor is Dr Tim Lancaster, Reader in Primary Health Care, University of Oxford. The other editors of the group are Professor Robert West, Cancer Research UK Health Behaviour Unit, Dr Paul Aveyard, University of Oxford and Professor John Hughes, University of Vermont.
The work of the group is supported by the UK Department of Health Research & Development Programme.